Blog
Category: Cloud Technology

Preparing for Cell and Gene Therapy 3.0

Blog

Patient data is mission-critical data — especially in cell and gene therapy.

In cell and gene therapy (CGT), the patient is the process is the…

Patient data – the unique role in cell and gene therapies (CGTs)

Blog

Patient data is mission-critical data — especially in cell and gene therapy.

In cell and gene therapy (CGT), the patient is the process is the…

Patient data – why it is critical for cell and gene therapy stakeholders

Blog

The first blog post in this series provided an overview of how the advanced therapies supply chain is different from traditional and biologic drug products…

Patient data – unique challenges, critical uses in the cell therapy value chain

Blog

The previous two blog posts in this series provided an overview of why patient-related data matters in cell therapy and gene therapy (CGTs), and how…

Integrated patient data – the future of advanced therapies

Blog

The cell and gene therapy (CGT) sector is poised for exponential growth — which will come in novel ways that reflect the unique nature of…

Autolomous and Vineti form strategic partnership to deliver end to end supply chain management solutions for cell and gene therapy sector

Blog

Autolomous LTD, the market leading developer of critical manufacturing management systems for cell and gene therapies, and Vineti, a provider of leading digital enterprise platforms…

Körber and Vineti Announce Partnership to Provide Improved Manufacturing Performance and Visibility Globally for Cell and Gene-Based Therapies

Blog

Körber, the leading MES supplier for pharma and biotech, and Vineti, the world’s only enterprise software platform supporting supply chain orchestration for clinical and commercial…

Life Sciences cybersecurity, knowing your first line of defense and continuously improving it

Blog

Pharmaceutical and biotech companies suffer more security breaches than any other industry1 — with greater than 20% of companies in the pharmaceutical sector having been…

Key industry and government regulations provide a cybersecurity foundation in advanced therapies

Blog

Pharmaceutical and biotech companies suffer more security breaches than any other industry1 — with greater than 20% of companies in the pharmaceutical sector having been…

Cybersecurity success in advanced therapies starts by prioritizing security as a “Way of working”

Blog

Pharmaceutical and biotech companies suffer more security breaches than any other industry1 — with greater than 20% of companies in the pharmaceutical sector having been…

Cybersecurity challenges in advanced therapies — introducing five strategies for success

Blog

Pharmaceutical and biotech companies suffer more security breaches than any other industry1 — with greater than 20% of companies in the pharmaceutical sector having been…

Lykan Bioscience and Vineti Announce Partnership to Advance Cell-based Therapies from Clinical to Commercialization

Blog

Lykan Bioscience’s world-class manufacturing capabilities, integrated with Vineti’s leading digital enterprise platform for cell and gene therapy supply chains, will streamline process development and manufacturing…